Literature DB >> 7977433

Bone loss after orthotopic liver transplantation.

E Meys1, E Fontanges, N Fourcade, A Thomasson, M Pouyet, P D Delmas.   

Abstract

PURPOSE: We assessed changes in body composition and bone loss following liver transplantation to determine if bone loss is related to the underlying liver disease or to other factors such as sex, menopause, or graft rejection episodes. PATIENTS AND METHODS: Our cross-sectional study component compared bone mass and body composition in 31 patients at 1 year after liver transplantation versus 33 pregraft patients with chronic liver disease. Bone mass was measured by dual energy X-ray absorptiometry (DXA) using anteroposterior views of the total body to determine bone mineral content (BMC), and of the lumbar spine to assess bone mineral density (BMD). The body fat content was also determined by DXA. Radiographs of the thoracic and lumbar spine were also obtained. In our longitudinal study component, 16 patients from the pregraft group underwent bone mass assessment again 1 year after transplantation.
RESULTS: Graft patients and pregraft patients both had reduced lumbar spine BMD compared to age- and sex-matched normal values (P < 0.001). A 4.75% increase in body fat content was observed after liver transplantation (P < 0.05). In the cross sectional study, bone mass of the spine and total body were not different in pre- and posttransplantation patients. However, the longitudinal study revealed significant decreases in spinal BMD and total body BMC, with a mean 3.5% decrease and a rate of loss of 0.55% per month. In addition, a dramatically high prevalence (29%) of vertebral fractures was observed in grafted patients, contrasting with a low prevalence (8.4%) of fractures in pregraft patients. Menopause, primary biliary cirrhosis, and chronic alcohol abuse were the principal contributing factors for osteoporosis. Patients with vertebral fractures had a marked 17.4% decrease of the lumbar spine BMD (P < 0.001) and a 22% decrease in total BMC when compared to patients without fractures (P < 0.01).
CONCLUSION: Patients with orthotopic liver transplantation for chronic liver disease evaluated 1 year after transplantation have a high prevalence of vertebral fractures. Cross sectionally, bone mass was not different in patients before and after transplantation, but the longitudinal study showed that liver transplantation induced a marked and rapid bone loss. Bone loss due to transplantation could enhance the risk of new vertebral fractures, as shown by the high prevalence of vertebral fractures. These results emphasize the need to identify patients with low bone mass by bone densitometry before transplantation.

Entities:  

Mesh:

Year:  1994        PMID: 7977433     DOI: 10.1016/0002-9343(94)90324-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery.

Authors:  L D Plank; D J Metzger; J L McCall; K L Barclay; E J Gane; S J Streat; S R Munn; G L Hill
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  Bone disease after liver transplantation should not be underestimated.

Authors:  J E Compston; G A Alexander
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 3.  Bone disease after liver transplantation.

Authors:  M S Losowsky; S H Hussaini
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 4.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 5.  Vitamin D in organ transplantation.

Authors:  E M Stein; E Shane
Journal:  Osteoporos Int       Date:  2011-01-05       Impact factor: 4.507

Review 6.  Osteodystrophy in chronic liver diseases.

Authors:  Pasquale Mansueto; Antonio Carroccio; Aurelio Seidita; Gaetana Di Fede; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2012-01-13       Impact factor: 3.397

7.  Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.

Authors:  J Pascual; J Torrealba; J Myers; S Tome; M Samaniego; A Musat; A Djamali
Journal:  Osteoporos Int       Date:  2007-04-03       Impact factor: 4.507

8.  Fracture incidence after liver transplantation: results of a 10-year audit.

Authors:  M O Premaor; T K Das; I Debiram; R A Parker; M Ninkovic; G T Alexander; J E Compston
Journal:  QJM       Date:  2011-03-08

9.  Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.

Authors:  G R Corazza; F Trevisani; M Di Stefano; S De Notariis; G Veneto; L Cecchetti; L Minguzzi; G Gasbarrini; M Bernardi
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 10.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.